How can researchers effectively collaborate with patients in the design and conduct of studies?

... double-blind study of adjuvant pembrolizumab (pembro) with V940 (mRNA-4157) or placebo for renal cell carcinoma (RCC). Based on the phase 3 KEYNOTE-564 trial ... Randomized double blind placebo control (RDBPC) studies are considered the “gold standard” of epidemiologic studies. Nov 1, 2022 ... C-POST Protocol Update: A Phase 3, Randomized, Double-Blind Study of Adjuvant Cemiplimab vs. Placebo Post Surgery and Radiation Therapy in ... A double-blind, randomized, prospective study was undertaken to determine if the dose of OKT3 used for induction immunosuppression following kidney and ... Jul 12, 2009 ... ... double-blind study in partial responders. A.C Altamura. ,. I Velonà. ,. R ... double-blind study, 28 patients with DSM-IV paranoid ... ... trials. We conducted a randomized, double-blinded, 7 arm clinical trial to: (1) identify the presence of a dose-response for complete protection from emesis ... Jun 27, 2018 ... This research study is being done to compare the effectiveness of either 15 or 30 mg once daily of upadacitinib versus adalimumab versus a placebo to control ... A RANDOMIZED, DOUBLE-BLIND STUDY TO ASSESS SERUM TRANSAMINASE ELEVATIONS AND ANTIBODY FORMATION FOLLOWING REPEAT SUBCUTANEOUS DOSING OF LMWH, UFH OR THE ... Feb 21, 1980 ... Controlled Double-Blind Study of the Effect of Rifampin on Humoral and Cellular Immune Responses in Patients with Pulmonary Tuberculosis and ... A Phase 2/3, Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod (RPC1063) ...